Bug fixes
A Phase 3, Multicenter, Randomized, Open Label Study Of Ifinatamab Deruxtecan (I Dxd), A B7-H3 Antibody Drug Conjugate (Adc), Versus Treatment Of Physician’s Choice (Tpc) In Subjects With Relapsed Small Cell Lung Cancer (Sclc). This app is specifically intended for participants in the ds7300-188 study only.
This version of DS7300 Android App comes with one universal variant which will work on all the Android devices.
If you are looking to download other versions of DS7300 Android App, We have 1 version in our database. Please select one of them below to download.